Sort
51,593 grants matching “hepatitis”
Responding to the Increase in Substance Use, HIV, HCV, and Overdose in New England (RISE-NE)
$2,076,525Angela Robertson Bazzi · University Of California, San Diego · U01 · FY2025 · DA
Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity
$2,076,274Ofer Levy · Boston Children'S Hospital · U19 · FY2021 · AI
HIV CENTERS FOR UNDEREPRESENTED POPULATIONS IN RESEARCH CTU (HIV CURE CTU)
$2,074,220Stephen A Spector · University Of California, San Diego · UM1 · FY2017 · AI
HIV CENTERS FOR UNDEREPRESENTED POPULATIONS IN RESEARCH CTU (HIV CURE CTU)
$2,074,220Stephen A Spector · University Of California, San Diego · UM1 · FY2016 · AI
TRANSFORMING CLINICAL AND TRANSLATIONAL RESEARCH AND EDUCATION AT ROCKEFELLER
$2,072,882Barry Coller · Rockefeller University · UL1 · FY2010 · RR
Mechanisms of Atherogenesis in Insulin Resistance
$2,072,208Ira A Tabas · Columbia University Health Sciences · P01 · FY2015 · HL
Assessing the Reach, Effectiveness, and Implementation of Multiple Harm Reduction Interventions.
$2,070,844Alexander H Kral · Research Triangle Institute · R01 · FY2022 · DA
Translational Multimodality " Antibody" Therapy
$2,069,586University Of California Davis · P01 · FY2004 · CA
Gene Therapy for Hemophilia
$2,069,413Katherine A High · Children'S Hosp Of Philadelphia · P01 · FY2012 · HL
Drug Metabolizing Enzymes In Humans And Animal Models
$2,068,287Joyce Goldstein · National Institute Of Environmental Health Sciences · ZIA · FY2011 · ES
Center for Protein Structure and Function
$2,068,071Francis S Millett · University Of Arkansas At Fayetteville · P20 · FY2006 · RR
The Military HIV Research Program (MHRP) Clinical Trial Unit
$2,065,103Merlin L Robb · Henry M. Jackson Fdn For The Adv Mil/Med · UM1 · FY2023 · AI
Liver Cirrhosis Network: Scientific and Data Coordination Center
$2,064,403Jody D. Ciolino · Northwestern University At Chicago · U24 · FY2023 · DK
Mechanisms Of Drug-induced Toxicities
$2,064,257Lance R Pohl · Heart, Lung, And Blood Institute · Z01 · FY2007 · HL
Environmental, Microbial and Mammalian Biomolecular Responses to AhR Ligands
$2,064,068Timothy R Zacharewski · Michigan State University · P42 · FY2024 · ES
Philadelphia HIV Therapeutics and Prevention Clinical Trials Unit
$2,063,841Pablo Tebas · University Of Pennsylvania · UM1 · FY2014 · AI
Therapy, Vaccine and Model Development in Viral Hepatitis and Liver Diseases
$2,063,799T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK
Molecular Approaches To Antiviral Development For Viral Hepatitis and Other Viral Diseases
$2,063,799T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK
Molecular Biology and Genetics of Human Tumor Viruses
$2,063,652Paul F Lambert · University Of Wisconsin-Madison · P01 · FY2017 · CA
Molecular Biology and Genetics of Human Tumor Viruses
$2,063,652Paul F Lambert · University Of Wisconsin-Madison · P01 · FY2013 · CA
Molecular Biology and Genetics of Human Tumor Viruses
$2,063,652Paul F Lambert · University Of Wisconsin-Madison · P01 · FY2016 · CA
Mechanisms of Atherogenesis in Insulin Resistance
$2,061,690Ira A Tabas · Columbia University Health Sciences · P01 · FY2014 · HL
Chicago Clinical Trials Unit
$2,057,977Robert L. Murphy · Northwestern University At Chicago · UM1 · FY2014 · AI
Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity
$2,057,593Ofer Levy · Boston Children'S Hospital · U19 · FY2020 · AI
Systems Biology of Insulin Resistance
$2,057,424Roger J Davis · Univ Of Massachusetts Med Sch Worcester · R24 · FY2014 · DK